"disease"
"Acute_Myeloid_Leukemia"
"Chronic_Myeloid_Leukemia"
"Acute_Lymphocytic_Leukemia"
"Breast_Cancer"
"Cancer"
"Melanoma"
"Non-small_Cell_Lung_Carcinoma"
"Lung_Acinar_Adenocarcinoma"
"Inflammatory_Myofibroblastic_Tumor"
"Neuroblastoma"
"Colorectal_Cancer"
"Papillary_Thyroid_Carcinoma"
"Skin_Melanoma"
"Multiple_Myeloma"
"Laryngeal_Squamous_Cell_Carcinoma"
"Gastrointestinal_Neuroendocrine_Tumor"
"Cholangiocarcinoma"
"Colorectal_Adenocarcinoma"
"Anaplastic_Thyroid_Carcinoma"
"Ganglioglioma"
"Ovarian_Cystadenocarcinoma"
"Ovarian_Cancer"
"Hairy_Cell_Leukemia"
"Langerhans-Cell_Histiocytosis"
"Renal_Cell_Carcinoma"
"Mantle_Cell_Lymphoma"
"Estrogen-receptor_Positive_Breast_Cancer"
"T-cell_Leukemia"
"Sarcoma"
"Lung_Adenocarcinoma"
"Lung_Small_Cell_Carcinoma"
"Malignant_Glioma"
"Hematologic_Cancer"
"Lung_Cancer"
"Colon_Cancer"
"Bladder_Carcinoma"
"Acute_Promyelocytic_Leukemia"
"Glioblastoma_Multiforme"
"Brain_Glioma"
"Polycythemia_Vera"
"Systemic_Mastocytosis"
"Gastrointestinal_Stromal_Tumor"
"Malignant_Anus_Melanoma"
"Pancreatic_Carcinoma"
"Pancreatic_Cancer"
"Pancreatic_Adenocarcinoma"
"Head_And_Neck_Squamous_Cell_Carcinoma"
"Thyroid_Cancer"
"Her2-receptor_Positive_Breast_Cancer"
"Head_And_Neck_Cancer"
"Thyroid_Medullary_Carcinoma"
"Stomach_Carcinoma"
"Invasive_Bladder_Transitional_Cell_Carcinoma"
"Her2-receptor_Negative_Breast_Cancer"
"Prostate_Cancer"
"Esophagus_Squamous_Cell_Carcinoma"
"Chronic_Lymphocytic_Leukemia"
"Colon_Carcinoma"
"Prostate_Carcinoma"
"Gastric_Adenocarcinoma"
"Esophagus_Adenocarcinoma"
"Cervical_Adenocarcinoma"
"Ovarian_Serous_Carcinoma"
"Uveal_Melanoma"
"Malignant_Mesothelioma"
"Ovarian_Carcinoma"
"Triple-receptor_Negative_Breast_Cancer"
"Ovarian_Serous_Cystadenocarcinoma"
"Chronic_Leukemia"
"Thymic_Carcinoma"
"Epithelial_Ovarian_Cancer"
"Endometrial_Cancer"
"Stomach_Cancer"
"Solid_Tumor"
"Leukemia"
"T-cell_Acute_Lymphoblastic_Leukemia"
""
"_2010)._Clinical_studies_are_currently_ongoing_(e.g._NCT01004224).		transcript_amplification		158"
"_Sci_Transl_Med		5	accepted	680	1885	8	38268656	38325363			ENST00000425967.3		NA	NA		75	GRCh37	FGFR1_amplifications_are_the_most_common_aberrations_of_the_FGFR_family_in_cancer._One_study_reports_FGFR1_aberrations_in_3.5%_of_4"
"_J._Clin._Oncol.		2	accepted	1909	1885	8	38268656	38325363			ENST00000425967.3		NA	NA		75	GRCh37	FGFR1_amplifications_are_the_most_common_aberrations_of_the_FGFR_family_in_cancer._One_study_reports_FGFR1_aberrations_in_3.5%_of_4"
"853_patients_of_which_most_are_FGFR1_amplifications_(Helsten_et._al."
"_2016)._Preclinically"
"_and_was_enriched_in_early_stages_(Freier_et._al."
"_Clin._Cancer_Res.		3	accepted	799	1885	8	38268656	38325363			ENST00000425967.3		NA	NA		75	GRCh37	FGFR1_high_expression_has_been_reported_in_11.8%_(178_patients)_of_oral_squamous_cell_carcinoma_patients"
"_AZD4547"
"_2007)._Another_study_reports_FGFR1_expression_in_35%_of_primary_HNSSC_(353_patients)_(Göke_et._al."
"_Br._J._Cancer		2	accepted	801	1885	8	38268656	38325363			ENST00000425967.3		NA	NA		75	GRCh37	FGFR1_high_expression_has_been_reported_in_11.8%_(178_patients)_of_oral_squamous_cell_carcinoma_patients"
"_assessed_by_mRNA_in_situ_hybridization)_was_identified_in_primary_CRC_tissue_samples.	24135816	PubMed	NA	Göke_et_al."
"_maintaining_the_kinase_domain_(Solomon_B"
"_J._Clin._Oncol.		3	accepted	1030	4941	6	117609463	117747018			ENST00000368508.3		NA	NA		75	GRCh37	ROS1_is_a_receptor_tyrosine_kinase_that_frequently_forms_gene_fusions_in_several_cancer_types._Approximately_2%_of_NSCLC_patients_harbor_a_ROS1_gene_fusion._Several_fusion_partners_have_been_described_with_a_constant_ROS1-breakpoint"
"_2015"
"_or_ALK_gene_fusions_Responses_were_observed_in_non-small_cell_lung_cancer"
"_where_known_ROS1_fusion_parters_SLC34A2"
"_J._Clin._Oncol.		3	accepted	1443	4941	6	117609463	117747018			ENST00000368508.3		NA	NA		75	GRCh37	ROS1_is_a_receptor_tyrosine_kinase_that_frequently_forms_gene_fusions_in_several_cancer_types._Approximately_2%_of_NSCLC_patients_harbor_a_ROS1_gene_fusion._Several_fusion_partners_have_been_described_with_a_constant_ROS1-breakpoint"
"_and_no_ALK_gene_rearrangement._CD72-ROS1_was_identified_in_sequencing_after_progression_on_chemotherapy._Crizotinib_at_250_mg_orally_twice_daily_led_to_resolution_of_metastatic_disease._The_patient_remained_disease-free_for_13_months_when_a_CT-scan_showed_a_relapse_with_two_nodules_in_the_right_lower_lobe._Stereotactic_"""
"Lung_Squamous_Cell_Carcinoma"
"Oropharynx_Cancer"
"Skin_Squamous_Cell_Carcinoma"
"Merkel_Cell_Carcinoma"
"Brain_Medulloblastoma"
"Basal_Cell_Carcinoma"
"Scrotum_Paget's_Disease"
"Uterine_Corpus_Serous_Adenocarcinoma"
"Salivary_Gland_Carcinoma"
"Biliary_Tract_Cancer"
"Uterine_Corpus_Endometrial_Carcinoma"
"Uterine_Cancer"
"Papillary_Renal_Cell_Carcinoma"
"Head_And_Neck_Carcinoma"
"Hepatocellular_Carcinoma"
"Malignant_Pleural_Mesothelioma"
"Bone_Ewing's_Sarcoma"
"Chordoma"
"Endometrial_Carcinoma"
"Pancreatic_Ductal_Adenocarcinoma"
"Esophageal_Carcinoma"
"Bile_Duct_Adenocarcinoma"
"Lung_Carcinoma"
"Anaplastic_Oligodendroglioma"
"Waldenström's_Macroglobulinemia"
"Renal_Carcinoma"
"Peritoneal_Mesothelioma"
"Chronic_Myeloproliferative_Disease"
"Angiosarcoma"
"Thyroid_Carcinoma"
"Colon_Mucinous_Adenocarcinoma"
"Peutz-Jeghers_Syndrome"
"Inflammatory_Breast_Carcinoma"
"Vagina_Sarcoma"
"Anaplastic_Large_Cell_Lymphoma"
"Diffuse_Large_B-cell_Lymphoma"
"Epithelioid_Inflammatory_Myofibroblastic_Sarcoma"
"Endometrial_Adenocarcinoma"
"Clear_Cell_Renal_Cell_Carcinoma"
"Liposarcoma"
"Dermatofibrosarcoma_Protuberans"
"Ewing_Sarcoma"
"Urothelial_Carcinoma"
"Myeloid_And_Lymphoid_Neoplasms_With_Eosinophilia_And_Abnormalities_Of_PDGFRA,_PDGFRB,_And_FGFR1"
"Mucosal_Melanoma"
"Plexiform_Neurofibroma"
"Papillary_Adenocarcinoma"
"Sezary's_Disease"
"Adult_B-Lymphoblastic_Leukemia"
"Chuvash_Polycythemia"
"Colon_Adenocarcinoma"
"Astrocytoma"
"Acoustic_Neuroma"
"Synovial_Sarcoma"
"Rhabdoid_Cancer"
"Malignant_Peripheral_Nerve_Sheath_Tumor"
"NUT_Midline_Carcinoma"
"Pediatric_Fibrosarcoma"
"Pediatric_B-lymphoblastic_Leukemia"
"Breast_Secretory_Carcinoma"
"Salivary_Gland_Cancer"
"Esophageal_Cancer"
"_Clin._Cancer_Res.		NA	accepted	4468	19		NA	NA					NA	NA		NA	GRCh37		Somatic_Mutation	2017-09-16_10:56:35_UTC	https://civic.genome.wustl.edu/links/evidence_items/4468	https://civic.genome.wustl.edu/links/variants/1181	https://civic.genome.wustl.edu/links/genes/19					0"
"_2006"
"_there_was_no_significant_difference_in_response_to_nilotinib_treatment_between_patients_with_mutations_in_the_Abl1_kinase_domain_versus_without._However"
"PubMed"
"Neuroendocrine_Tumor"
"Oligodendroglioma"
"Desmoid_Fibromatosis"
"Ovarian_Clear_Cell_Carcinoma"
"Follicular_Thyroid_Carcinoma"
"NC_000009.11:g.133753889A>C"
"_1/1_had_a_major_cytogenetic_response.	21865346	PubMed	NA	Cortes_et_al."
"_Mol_Oncol		NA	accepted	4623	6	17	41199682	41199682	C	T			NA	NA		NA	GRCh37		Somatic_Mutation	2018-07-06_14:38:48_UTC	https://civic.genome.wustl.edu/links/evidence_items/4623	https://civic.genome.wustl.edu/links/variants/1555	https://civic.genome.wustl.edu/links/genes/6			stop_gained		0"
"_Br._J._Dermatol.		NA	accepted	4654	5365	7	128846398	128846398	C	T	ENST00000249373.3		NA	NA		75	GRCh37		Somatic_Mutation	2017-07-20_15:22:44_UTC	https://civic.genome.wustl.edu/links/evidence_items/4654	https://civic.genome.wustl.edu/links/variants/1570	https://civic.genome.wustl.edu/links/genes/5365			missense_variant	NM_005631.4:c.1234C>T"
"_World_J_Surg_Oncol		NA	accepted	4655	19		NA	NA					NA	NA		NA	GRCh37		Somatic_Mutation	2018-01-18_23:33:33_UTC	https://civic.genome.wustl.edu/links/evidence_items/4655	https://civic.genome.wustl.edu/links/variants/1571	https://civic.genome.wustl.edu/links/genes/19					0"
"_World_J_Surg_Oncol		NA	accepted	4656	19		NA	NA					NA	NA		NA	GRCh37		Somatic_Mutation	2018-01-18_23:32:47_UTC	https://civic.genome.wustl.edu/links/evidence_items/4656	https://civic.genome.wustl.edu/links/variants/1572	https://civic.genome.wustl.edu/links/genes/19			missense_variant		0"
"_World_J_Surg_Oncol		NA	accepted	4657	19		NA	NA					NA	NA		NA	GRCh37		Somatic_Mutation	2018-01-18_23:32:25_UTC	https://civic.genome.wustl.edu/links/evidence_items/4657	https://civic.genome.wustl.edu/links/variants/1573	https://civic.genome.wustl.edu/links/genes/19					0"
"_World_J_Surg_Oncol		NA	accepted	4658	19	7	55249092	55249092	G	A	ENST00000275493.2		NA	NA		75	GRCh37		Somatic_Mutation	2018-01-18_23:32:06_UTC	https://civic.genome.wustl.edu/links/evidence_items/4658	https://civic.genome.wustl.edu/links/variants/1574	https://civic.genome.wustl.edu/links/genes/19			missense_variant	ENST00000275493.2:c.2390G>A	0"
"_World_J_Surg_Oncol		NA	accepted	4659	19		NA	NA					NA	NA		NA	GRCh37		Somatic_Mutation	2018-01-18_23:31:47_UTC	https://civic.genome.wustl.edu/links/evidence_items/4659	https://civic.genome.wustl.edu/links/variants/1575	https://civic.genome.wustl.edu/links/genes/19					0"
"_Cancer_Biol._Ther.		4	accepted	2156	19		NA	NA					NA	NA		NA			Somatic_Mutation	2017-10-02_20:42:41_UTC	https://civic.genome.wustl.edu/links/evidence_items/2156	https://civic.genome.wustl.edu/links/variants/1854	https://civic.genome.wustl.edu/links/genes/19			missense_variant"
"_P<0.0001"
"_P_<_0.001)_and_median_overall_survival_(15.0_vs._10.4_months"
"_and_overall_survival_were_20%"
"_P<0.001)_median_progression_free_survival_(5.0_vs_2.0_months"
"_progression_free_survival_(PFS)_of_1.0_months"
"_nonsmoker)_had_a_partial_response"
"_smoker)_had_progressive_disease_as_response"
"_nonsmoker)_had_progressive_disease_as_response"
"_nonsmoker)_progressive_disease_as_response"
"_compared_to_carboplatin_plus_paclitaxel_treatment._The_frequency_of_mutation_in_exon_19_deletion_and_L858R_was_53.6%_(140/261)_and_42.5%_(111/261)"
"_J_Thorac_Oncol		3	accepted	5929	70		NA	NA					NA	NA		NA			Somatic_Mutation	2018-02-15_13:05:52_UTC	https://civic.genome.wustl.edu/links/evidence_items/5929	https://civic.genome.wustl.edu/links/variants/2211	https://civic.genome.wustl.edu/links/genes/70					3"
"_and_decreased_nuclear_BRCA1_protein_localization._BARD1β_sensitizes_colon_cancer_cells_to_poly_ADP_ribose_polymerase_1_(PARP-1)_inhibition_even_in_a_BRCA1_WT_background.	27197561	PubMed	NA	Ozden_et_al."
"_vemurafenib"
"_G13R"
"Chronic_Neutrophilic_Leukemia"
"Congenital_Fibrosarcoma"
"Pediatric_B-cell_Acute_Lymphoblastic_Leukemia"
